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Abstract 
 Plasmodium falciparum lipoate protein ligase 1 (PfLipL1) is an ATP-dependent ligase 
that belongs to the biotin/lipoate A/B protein ligase family (PFAM PF03099). PfLipL1 is the 
only known canonical lipoate ligase in Pf and functions as a redox switch between two 
lipoylation routes in the parasite mitochondrion. Here, we report the crystal structure of a 
deletion construct of PfLipL1 (PfLipL1∆243-279) bound to lipoate, and validate the lipoylation 
activity of this construct in both an in vitro lipoylation assay and a cell based lipoylation assay. 
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This characterization represents the first step in understanding the redox dependence of the 
lipoylation mechanism in malaria parasites. 
 
Introduction 
 In humans, malaria is caused by five species of Apicomplexan parasites of which P. 
falciparum is the deadliest. 1-3 The parasite lifecycle includes a sexual reproductive stage in the 
mosquito vector and two asexual reproductive cycles in the human host, namely the liver stage 
(asymptomatic) and the blood stage (symptomatic). The majority of available drugs target the 
blood stage;4 although, recent findings suggest an increase of drug resistance in certain 
populations of parasites.3,5-7 
 The rise in drug resistance has created a necessity for new viable drug targets for malaria 
treatment. Lipoate metabolism is one such pathway. Lipoate is an organosulfur cofactor for a 
small number of enzymes that are essential for malaria parasite survival.8,9 P. falciparum has two 
distinct organelles that contain independent pathways for lipoate metabolism.8,10 The apicoplast, 
a non-photosynthetic plastid organelle, contains a biosynthetic pathway that is dispensable in the 
blood stage but is essential for progression from the liver to the blood stage.10-12 In contrast to the 
apicoplast, the mitochondrion relies exclusively on lipoate scavenged from the host red blood 
cell and this pathway is essential for both the liver and blood stages.8,12,13 Treatment with lipoate 
analogs, 8-bromooctanoate or 6,8-dichlorooctanoate, results in parasite growth inhibition likely 
due to reduced substrate lipoylation.8,14 
 There are three lipoylated enzymes in the parasite mitochondrion: the E2 component of 
the branched chain a-ketoacid dehydrogenase complex (BCDH, PF3D7_0303700), the E2 
component of the α-ketoglutarate dehydrogenase complex (KDH, PF3D7_1320800), and the H-
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protein of the glycine cleavage system (PF3D7_1132900).9,14,15 The lipoylation of these three 
proteins occurs via a complex mechanism that involves two enzymes, PfLipL1 
(PF3D7_1314600) and PfLipL2 (PF3D7_0923600). PfLipL1 has been shown to be the only 
canonical lipoate ligase and is solely responsible for lipoylation of the H-protein – a reaction that 
only occurs when lipoate is in the oxidized ring form.14 The lipoylation of BDCH and KDH 
requires both PfLipL1 and PfLipL2 as well as fully reduced lipoate (dihydrolipoate).14 Although 
the mechanistic implications of redox dependence in the parasite remain unclear, PfLipL1 is the 
switch that senses the oxidation state of lipoate and determines which downstream enzymes will 
be lipoylated.16 As a first step in understanding of the molecular determinants of lipoylation 
activity and redox sensing in PfLipL1 we determined the structure of lipoate-bound PfLipL1 ∆243-
279. 
Materials and Methods 
Plasmid construction 
 Plasmid pMALcHT-PfLipL114 was mutated to generate pMALcHT-PfLipL1∆259-269, 
pMALcHT-PfLipL1∆254-274, and pMALcHT-PfLipL1∆249-279 using the primers listed in Table S1. 
Mutating the pMALcHT-PfLipL1∆249-279 plasmid using the primers listed in Table S1 then 
generated the plasmid pMALcHT-PfLipL1∆243-279. The pMALcHT plasmid encodes a maltose 
binding protein (MBP) followed by a linker region composed of a tobacco etch virus (TEV) 
protease cut site and a six histidine affinity tag.17  
Protein expression and purification 
 All constructs were transformed into BL21-Star (DE3) cells (Invitrogen) containing the 
pRIL plasmid isolated from BL21-CodonPlus-RIL cells (Agilent) and plasmid pRK586 encoding 
the Tobacco Etch Virus (TEV) protease as described.17 These cells produce a protein product 
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fused to an amino-terminal hexahistidine tag. 2L of TB media containing ampicillin, kanamycin, 
and chloramphenicol were inoculated with an overnight culture for an initial OD600 of 
approximately 0.1. The cells were grown to mid log phase at 37ºC and then the temperature was 
reduced to 20ºC. Protein expression was induced with 0.4 mM Isopropyl β-D-1-
thiogalactopyranoside (IPTG) and the cells were harvested after 10h. Purification was performed 
as described previously for full-length PfLipL1.14 Briefly, PfLipL1 variants were purified by 
immobilized metal ion chromatography followed by cation exchange chromatography and gel 
filtration chromatography. The first two steps of purification were performed on the same day to 
avoid proteolytic cleavage. Purified PfLipL1 mutants were concentrated to approximately 5 
mg·mL-1 and stored at -80ºC. 
Protein crystallization and data collection 
 Lipoyl-PfLipL1∆243-279 complex was prepared by adding 1.2 mol equiv of lipoate and 
excess ATP to 5 mg·mL-1 apo-LipL1∆243-279. Original crystals were obtained from a screen set up 
with 200 nL of protein and 200 nL reservoir containing 100 mM HEPES, pH 7.0 and 1.5 M 
(NH4)2SO4 using a Mosquito crystallization robot (TTP Labtech) and equilibrated at 20 ºC in a 
96-well sitting drop Intelli-Plate® (Art Robbins Instruments). The crystallization condition was 
further optimized to obtain larger crystals with 1 µL protein and 1 µL reservoir containing 100 
mM HEPES, pH 7.0, 1.5 M (NH4)2SO4, and 20% ethylene glycol and equilibrated at 20ºC on a 
24-4 sitting drop Intelli-Plate® (Art Robbins Instruments). Crystals were mounted on a 0.2 mm 
cryoloop (Hampton Research) and flash frozen in liquid nitrogen for data collection. Data sets 
were collected at SSRL beam line 7-1 at 100K and λ 1.127085 Å.  
Structure determination 
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 The crystals belonged to the P3221 space group with cell dimensions of a = b = 120.24 Å, 
c = 134.92 Å, α = β = 90°, and γ = 120°. Data reduction and scaling were performed with 
XDS/XSCALE.18-20 The molecular replacement solution was obtained using alanine-substituted 
E. coli LplA (EcLplA; PDB: 3A7A, chain A) N-terminal domain and C-terminal domain search 
models with the Phaser-MR module in PHENIX.21,22 Model building was performed in Coot 23 
and refinement in PHENIX. Lipoate-bound PfLipL1∆243-279 was refined to a crystallographic 
Rwork of 27.3% and an Rfree of 30.2%. the final structure was analyzed with validation tools in 
MOLPROBITY.24,25 Protein sequence similarity and Z-scores were calculated using the Dali 
server.26 Sequence alignments were performed using the Clustal algorithm in Jalview.27-29 
Structural visualization was performed via PyMol.30 
In vitro lipoylation assay  
 Lipoylation assays were performed as previously described.14 Briefly, purified PfLipL1 
variants (1 µM) were incubated in reaction buffer (100 mM Na/K phosphate at pH 7.5 and 150 
mM NaCl) containing 2 mM ATP, 2 mM MgCl2, 200 µM R-lipoic acid, and 10 µM H-protein. 
After a 1-hour incubation at 37ºC reactions were quenched with the addition of gel loading 
buffer and analyzed by Western blot. The SDS-PAGE gel was transferred to a nitrocellulose 
membrane, blocked with 5% milk in PBS for 30 min, and probed with 1:5000 rabbit polyclonal 
α-LA (Calbiochem) for 2 h in 1% milk/PBS at room temperature. The membrane was washed 
with PBS three times and then probed with 1:5000 donkey α-Rabbit IgG horseradish peroxidase 
(HRP) secondary antibody (GE Healthcare) in 1% milk/PBS overnight at 4°C. The membranes 
were visualized with ECL western substrate (Pierce) and exposed to film. 
Cell-based lipoylation assay  
 Cell based lipoylation was performed as previously described.14 Briefly, lipoylation 
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deficient E. coli strain JEG3 containing the pRIL plasmid was transformed with a plasmid 
containing the candidate lipoate ligase (pMALcHT-PfLipL1, pMALcHT-PfLipL1∆259-269, 
pMALcHT-PfLipL1∆254-274, pMALcHT-PfLipL1∆249-279, or pMALcHT-PfLipL1∆243-279). Cells 
were subsequently grown in LB medium with 1% glucose, 5 mM sodium succinate, 5 mM 
sodium acetate, 35 µg ·mL-1 chloramphenicol, 100 µg ·mL-1 ampicillin, and 200 µM R-lipoic 
acid. 20 mL cultures were grown to mid-log phase at 37ºC and induced with 0.4 mM IPTG for 
10 h at 20ºC. Cells were harvested by centrifugation and re-suspended with 0.5 mL of buffer 
containing 20 mM HEPES, 100 mM NaCl at pH 7.5 and lysed by sonication. Cell lysates were 
clarified by centrifugation at 16 000 g and the supernatants were collected and resolved by SDS-
PAGE (Invitrogen). Lipoylated proteins were visualized by Western blot as described above.  
Accession code 
The atomic coordinates and structure factors have been deposited in the Protein Data  
Bank as entry 5T8U 
Results & Discussion 
Overall Structure 
 To further our understanding into the lipoylation mechanism in malaria parasite 
mitochondria, we crystallized PfLipL1∆243-279 in the presence of lipoate and excess ATP. The 
resulting crystals only contained lipoate bound in the active site presumably due to degradation 
of the lipoyl-AMP conjugate during the process of crystallization or trapping of the lipoyl-bound 
form in the crystal lattice. Lipoate-bound PfLipL1∆243-279 crystallized in the trigonal P3221 space 
group and has cell dimensions of a = b = 120.24 Å, c = 134.92 Å, α = β = 90°, and γ = 120° with 
two monomers per asymmetric unit. The structure was solved using an alanine-substituted model 
of EcLplA (PDB code 3A7A, chain A). The N-terminal domain (residues 1-243) and C-terminal 
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domain (residues 250-337) were used as independent search models. Lipoyl-PfLipL1∆243-279 was 
refined to 2.3 Å resolution with an Rwork of 27.28% and an Rfree of 30.16%. The crystallographic 
data and refinement statistics are summarized in Table 1. The Rfree value is high given the 
resolution but after multiple rounds of refinement taking into account various factors, such as 
restraints and B-factors, it was not possible to obtain a lower Rfree value. Analysis of the data 
with PHENIX Xtriage and POINTLESS do not suggest contributions from twinning or 
translational non-crystallographic symmetry. Furthermore, analysis with ZANUDA in CCP4 is 
consistent with the P3221 space group used in this study. 
31 Thus, we hypothesize that the high 
Rfree value may be due a small but significant amount of degradation that is observed during the 
purification process. 
 The lipoate-bound PfLipL1∆243-279 structure (Fig 1A) consists of a large N-terminal 
domain (NTD, residues 21-276), a linker region lacking defined secondary structure (residues 
277-289), and a small C-terminal domain (CTD, residues 290-370). The NTD contains two β-
sheets, a large mixed β -sheet made up of seven β -strands (β1, β2, β6, β7, β8, β9, and β10) and 
a small mixed-sheet made up of three strands (β3, β4, and β5). There are six α-helical elements 
surrounding the β-sheets (α1-6). The CTD consists of one anti-parallel β-sheet made up of three 
strands (β11, β12, and β13) and three α-helices (α7, α8, and α9). The two monomers in the 
asymmetric unit are in similar conformations and superimpose with a root-mean-square 
deviation (r.m.s.d.) of 0.4 Å for the corresponding 269 Cα atoms (Fig 1B). The most notable 
differences between the two monomers are a lack of density in Chain B residues 242-247 (a 
flexible loop at the site of the deletion) and an extension of the Chain B adenylate-binding loop 
at residues 194-200. The latter extension forms a β-strand with a symmetry related monomer. 
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 Figure 1C shows a LIDIA diagram of the lipoate binding site in Chain A of the 
PfLipL1∆243-279 structure.
32 Here, residues that are involved in hydrophobic interactions are 
shown in lime green and residues involved in H-bond interactions are shown as blue and green 
dashed lines for main chain and side chain interactions, respectively. It is important to note one 
additional difference between Chain A and Chain B in reference to the lipoate binding site. In 
Chain B it is the side chain of residue N152 as opposed to the amide hydrogen of residue G107 
that forms the second hydrogen bond with the lipoate carboxylate.  
 Figures 1D and 1E show a close-up view of the lipoate binding pocket of PfLipL1∆243-279 
where residues that show significant interactions with the lipoate moiety are highlighted in stick 
representation and colored red (hydrophobic interactions) or blue (H-bond interactions). The 
pocket is defined by interactions with residues from β2, β5, β9, β10, and the loop region between 
β4 and β5, known as the lipoate-binding loop (residues 101-106). The lipoate binding loop is a 
hallmark of all lipoate protein ligases and lipoate transferases. It is of special interest to highlight 
the hydrogen bonding interaction between the lipoate carbonyl and residue K160. Lipoate ligase 
enzymes are characterized by having an active site lysine that forms hydrogen bonds with both 
lipoate and ATP orienting the carboxylate of lipoate for a nucleophilic attack on the α-
phosphorus atom of ATP.33 Indeed, an alanine substitution of K160 renders full-length PfLipL1 
unable to form lipoyl-AMP and abrogates lipoylation activity in vitro.14 
 Structure comparison 
 We searched for proteins with structural similarity to PfLipL1∆243-279 using the Dali 
server.26 Generally, the Dali server measures similarity by a sum-of-pairs method that results in a 
Dali-Z score. Structures with a Dali-Z- score above 2 are considered to have significant 
similarity and will usually be characterized as having similar folds. The top scoring result from 
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the Dali server for PfLipL1∆243-279 is a computationally designed resorfurin ligase that was 
designed based on the EcLplA scaffold (PDB: 4TVY, Z-score: 32.4).34 Additionally, apo-, 
lipoate-bound, and lipoyl-AMP-bound EcLplA structures also have a high Z-score in the Dali 
server results (PDBs: 1X2G, 1X2H, 3A7R; Z-scores: 31.1, 31.1, 30.5, respectively). A sequence 
alignment of PfLipL1∆243-279 and EcLplA shows all secondary structure elements to be conserved 
and a percentage identity of 29.8% (Fig. 2A).  
 The structure of lipoate-bound PfLipL1∆243-279 is in the same “bent” conformation as the 
EcLplA structure in the “unliganded” form (Fig 2B).33,35 In this conformation the CTD is bent 
such that it obscures the putative H-protein binding site in a similar mechanism as that observed 
for EcLplA.33 This conformation is characterized by a hydrogen bond between the amide of 
G106 of the lipoate-binding loop and the carbonyl of C321 in the CTD. Additionally, there is a 
conserved salt-bridge between residues K79 in the NTD and D328 in the CTD. Similar 
interactions can also be observed in the EcLplA structures in the “bent” conformation. 
Comparison of the lipoate-bound- PfLipL1∆243-279 to lipoyl-AMP-bound EcLplA (Fig 2C) shows 
that a large structural rearrangement must occur in PfLipL1∆243-279 to accommodate H-protein for 
lipoylation. 
PfLipL1 deletion mutants are characterized by wild-type like lipoylation activity in vitro 
 Although full-length PfLipL1 can be easily expressed and purified from E. coli with high 
yield, this construct is prone to spontaneous proteolytic cleavage. Amino acid sequencing 
revealed that cleavage initially occurs between K264 and E265 (data not shown); however, 
alanine substitution at position 264 does not prevent degradation even in the presence of protease 
inhibitors (data not shown). PfLipL1 contains a low complexity region that is not conserved in 
other characterized lipoate ligases and despite the presence of this region in other Plasmodium 
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species there is no conservation of sequence or size. Full-length PfLipL1 crystals can still be 
generated but only diffract to low resolution. We therefore decided to make a series of mutations 
that removed the low complexity sequence from our construct and tested the mutant PfLipL1 
constructs both in a cell-based lipoylation assay and an in vitro lipoylation assay. We made three 
different deletion mutants removing 5, 10 or 15 residues on both sides of K264 (deleting a total 
of 11, 21 or 31 amino acids, respectively). These constructs still suffered from degradation, 
prompting us to make a fourth deletion (PfLipL1∆243-279) removing more residues from the low 
complexity loop. The latter construct, PfLipL1∆243-279, shows minor degradation but is far more 
stable than the full-length construct. All loop deletion constructs appear to be enzymatically 
active. Indeed, E. coli substrate proteins are lipoylated when all PfLipL1 variants are expressed 
in a lipoylation deficient cell line (Fig S1A). Furthermore, in vitro lipoylation of the PfH-protein, 
a canonical substrate enzyme, remains unchanged in the PfLipL1∆243-279 deletion mutant (Fig 
S1B). Since the lipoylation activity of all PfLipL1 variants remains unchanged with deletion of 
the low complexity region the PfLipL1∆243-279 construct is likely a good structural surrogate to 
understand the mechanism of lipoylation in P. falciparum. 
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Figure Captions 
 
Fig 1. Overall structure and binding pocket of lipoate-bound PfLipL1∆243-279. (A) Cartoon 
representation of chain A of lipoate-bound PfLipL1∆243-279. Secondary structure elements are 
labeled and the lipoate moiety is shown in stick representation. Important residues for the 
binding pocket are shaded in red and blue for residues contributing hydrophobic and H-bond 
interactions, respectively. (B) Superposition of chain A (cyan) and chain B (red) of lipoate-
bound PfLipL1∆243-279. The major differences in the two monomers are the lack of density for the 
loop defined by residues 242-247 and the extension of the adenylate-binding loop. (C) LIDIA 
representation of the binding site of Chain A. Residues involved in hydrophobic interactions are 
represented as lime green circles and residues involved in H-bond interactions are represented as 
blue or green dashed lines for main chain or side chain interactions, respectively. (D) and (E) 
surface representation of the lipoate binding pocket. Important residues are shown in stick 
representation and colored blue or red for or H-bonds or hydrophobic interactions, respectively. 
H-bonds are represented as blue dashed lines. 
 
Fig 2 Comparison of PfLipL1and EcLplA. (A) Clustal sequence alignment of full-length 
PfLipL1 and EcLplA. Residues are colored using the ClustalX color scheme. Secondary 
structure elements are labeled as follows: arrows represent β-strands and rectangles represent α-
helices. The lipoate-binding loop is highlighted with a grey-dashed line between β4 and β5 and 
the adenylate-binding loop is highlighted with a grey dashed line between and β10 and α5. The 
site of proteolytic cleavage in full length PfLipL1 is marked with a red asterisk (B) Overlay of 
lipoate-bound PfLipL1∆243-279, colored cyan, and lipoate bound EcLplA (PDB 1X2H), colored 
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slate generated by the RAPIDO server.36,37 Both structures are considered to be in the “bent” 
conformation which is incompatible with binding substrate proteins. (C) Overlay of lipoate-
bound PfLipL1∆243-279, colored cyan, and lipoyl-AMP bound EcLplA (PDB 3A7R), colored 
salmon. The CTD of EcLplA has translated approximately 90º and rotated approximately 180º to 
accommodate substrate enzyme binding. It is of interest to note the formation of a small β-strand 
in the CTD from residues that belong to the long adenylate-binding loop. 
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Table 1.  Data collection and refinement statistics for lipoate-bound PfLipL1∆243-279  
Data Collection  
Resolution range (Å) 44.97 - 2.32 (2.41 - 2.32) 
Total reflections 289251 (28279) 
Unique reflections 48819 (4399) 
Multiplicity 5.9 (5.8) 
Completeness (%) 96.5 (90.4) 
Mean I/sigma(I) 9.9 (0.6) 
R-merge 0.139 (2.672) 
CC1/2 0.998 (0.491) 
CC* 0.999 (0.812) 
Wilson B-factor (Å2) 53.07 
Space group P 32 2 1 
Unit cell  
    a, b, c (Å) 120.2, 120.2, 134.9 
    α, β, γ (º) 90, 90, 120 
  
Refinement  
Reflections used in refinement 47298 
Reflections used for R-free 2309 
R-work (%) 27.28 
R-free (%) 30.16 
Molecules in asymmetric unit 2 
Number of non-hydrogen atoms 5594 
    macromolecules 5486 
    ligands 24 
    solvent 84 
Protein residues 671 
Ramachandran favored / outliers 
total 
 
624 / 1 
(%) 95 / 0.15 
Rotamer outliers (%) 0.33 
Average B-factor (Å2) 79.65 
    macromolecules (Å2) 80.06 
    ligands (Å2) 88.07 
    solvent (Å2) 50.41 
RMS bonds (Å) / angles (º) 0.002 / 0.47 
RMSZ bonds / angles 0.24 / 0.42 
Statistics for the highest-resolution shell are shown in parentheses. 
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